Product Information
CLONIDINE HCL ER 0.17 MG TAB is a generic product labeled by PALMETTO PHARMACEUTICALS INC., priced at $12.8900 per EA under NDC 68134060330. Its NADAC has been published 33 times since Jul 17, 2024.
FDA first approved this application on Dec 3, 2009.
Strength
.17 mg/1
Manufacturer
PALMETTO PHARMACEUTICALS INC.NDC
68134060330
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
12/18/2024
Active Ingredients
CLONIDINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022500FDA Approved
12/3/2009
On Market Since
3/1/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONIDINE HCL ER 0.17 MG TAB has been published 33 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.8900 per EA |
|---|---|
| All-time high | $12.9976 (Oct 16, 2024) |
| All-time low | $12.7280 (Jul 17, 2024) |
| Median price | $12.8900 |
| Average price | $12.8621 |
| Largest weekly change | +2.1% (Sep 18, 2024) |
| Weeks tracked | 33 |
| Tracking since | Jul 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+1.3%
Last surveyed Feb 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PALMETTO PHARMACEUTICALS INC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clonidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLONIDINE HCL ER 0.17 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CLONIDINE HCL ER 0.17 MG TAB, manufactured by PALMETTO PHARMACEUTICALS INC., is $12.8900 per EA (NDC 68134060330), effective Feb 26, 2025.
How has the price of CLONIDINE HCL ER 0.17 MG TAB changed over time?
Over the history we have for it, the NADAC for CLONIDINE HCL ER 0.17 MG TAB has held within roughly two percent of its current level. It has been tracked across 33 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for CLONIDINE HCL ER 0.17 MG TAB?
Since Jul 17, 2024, the NADAC for CLONIDINE HCL ER 0.17 MG TAB has ranged from a low of $12.7280 (Jul 17, 2024) to a high of $12.9976 (Oct 16, 2024), with a median of $12.8900 per EA.
Are there cheaper alternatives to CLONIDINE HCL ER 0.17 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLONIDINE HCL ER 0.17 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONIDINE HCL ER 0.17 MG TAB?
CLONIDINE HCL ER 0.17 MG TAB (NDC 68134060330) is labeled by PALMETTO PHARMACEUTICALS INC., and CMS classifies it as a generic product.